SCHEMBL3077217

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL3087912	0.90	AR (0.39)	ARNOTUMNSD2TLR8
	SCHEMBL3075833	0.86	AR (0.44)	ARNSD2ALDH1A1LMNAMAPT
	SCHEMBL3081376	0.85	AR (0.49)	ARNSD2
	SCHEMBL3077429	0.84	AR (0.50)	ARNSD2ALDH1A1MAPTKDM4E
	SCHEMBL3070012	0.84	AR (0.50)	ARNSD2ALDH1A1MAPTKDM4E
	SCHEMBL3074078	0.82	AR (0.48)	ARNSD2ALDH1A1MAPTKDM4E
	SCHEMBL3081423	0.82	AR (0.48)	ARNSD2MAPT
	SCHEMBL3063842	0.82	AR (0.48)	ARNSD2KDM4ETSHR
	SCHEMBL3087297	0.82	AR (0.62)	ARNSD2
	SCHEMBL3081229	0.82	AR (0.50)	ARNSD2NPC1ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.